4.6 Article

Efficacy of adipose tissue-derived mesenchymal stem cells for fulminant hepatitis in mice induced by concanavalin A

Related references

Note: Only part of the references are listed.
Review Oncology

Bone marrow-derived mesenchymal stem cells and the tumor microenvironment

Scott A. Bergfeld et al.

CANCER AND METASTASIS REVIEWS (2010)

Article Medicine, General & Internal

Acute liver failure

William Bernal et al.

LANCET (2010)

Review Cell & Tissue Engineering

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

Soufiane Ghannam et al.

STEM CELL RESEARCH & THERAPY (2010)

Article Hematology

Mesenchymal stem cells suppress B-cell terminal differentiation

Sadaki Asari et al.

EXPERIMENTAL HEMATOLOGY (2009)

Article Gastroenterology & Hepatology

Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure

Agnieszka Banas et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)

Article Immunology

The Immunosuppressive Properties of Mesenchymal Stem Cells

Georg Siegel et al.

TRANSPLANTATION (2009)

Article Gastroenterology & Hepatology

Etiology and prognosis of fulminant hepatitis in adults

Philippe Ichai et al.

LIVER TRANSPLANTATION (2008)

Article Biochemical Research Methods

Adipose-derived stem cells: Isolation, expansion and differentiation

Bruce A. Bunnell et al.

METHODS (2008)

Article Multidisciplinary Sciences

Mesenchymal Stem Cells in Early Entry of Breast Cancer into Bone Marrow

Kelly E. Corcoran et al.

PLOS ONE (2008)

Article Immunology

Long-term problems related to immunosuppression

Manuel Miras Lopez et al.

TRANSPLANT IMMUNOLOGY (2006)

Article Multidisciplinary Sciences

Critical contribution of liver natural killer T cells to a murine model of hepatitis

K Takeda et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)